Company Profile
Who We Are
Helene Theraputics is a biopharmaceutical group focused on the development of advanced cell-based therapeutics through an integrated platform combining clinical infrastructure, manufacturing capabilities, and data-driven development.
Our Approach
Our model integrates clinical access, cell processing, and therapeutic development within a unified system. Through our global clinical network, we obtain direct access to patients and longitudinal clinical data, enabling real-world insights into safety, efficacy, and treatment outcomes.
These insights are systematically incorporated into our development process, supporting the standardization of protocols, optimization of manufacturing, and progression toward regulated therapeutic products.
Integrated Platform
Our platform consists of four core components:
- Therapeutic Development
Development of autologous and allogeneic cell-based therapeutics
- Manufacturing & Quality Control
Standardized processing, quality control, and defined release criteria
- Global Clinical Network
Controlled patient access and real-world data generation
- Cell Banking Infrastructure
Long-term storage, traceability, and scalability of cell-based product
Data-Driven Development
Clinical data is a central asset within our platform.
We capture longitudinal patient data across our network, generating real-world evidence that supports therapeutic optimization, regulatory strategy, and long-term value creation.
Global Operating Model
Our global structure is designed to integrate clinical practice with therapeutic development:
London
Translational R&D and regulatory alignment hub
Tokyo
Clinical access and data generation hub in Asia
UAE / Asia Network
Expansion of access, capital networks, and operational scalability
Our Objective
Our objective is to transform clinical experience into standardized, scalable, and regulated cell-based therapeutics, bridging the gap between treatment and biopharmaceutical development.